Comparing the current results to its competitors, Enhabit Inc reported Revenue increase in the 1 quarter 2026 by 1.89 % year on year. The revenue growth was below Enhabit Inc 's competitors' average revenue growth of 6.61 %, achieved in the same quarter.
Enhabit Inc 's Comment on Competition and Industry Peers
The company distinguishes itself through its scale and density in targeted markets, a disciplined operating model focused on technology and clinical expertise, high-quality outcomes, and an award-winning culture. These attributes support partnerships with health systems, payers, and other risk-bearing entities, facilitating adaptation to regulatory changes aimed at improving outcomes and reducing costs. Since 2015, the company has invested over $798 million in 42 home health and hospice acquisitions, fully integrating them into its operations.
January 31, 2025
In a noteworthy achievement, Enhabit, Inc. (NYSE: EHAB), a prominent home health and hospice services provider, has garnered the esteemed Great Place to Work certification for 2025. This recognition is particularly remarkable as it is rooted in the authentic experiences of the company s current employees. According to this year s evaluation, an impressive 83% of Enhabit employees affirm that their workplace fosters a positive and rewarding environment, significantly exceeding the average U.S. company score by 26 points.Great Place to Work, a global authority on workplace culture and employee experience, bases its accolades on rigorous evaluations that reflect employee sentiment across various dimensions of t...
May 24, 2024
Dallas-based technology company Enhabit, Inc. (NYSE: EHAB) has recently unveiled additional details regarding its robust strategic review process. The company aims to enhance its business operations and drive accelerated growth, as outlined in the preliminary proxy materials filed with the Securities and Exchange Commission (SEC) for its upcoming 2024 annual meeting of stockholders.Enhabit s preliminary proxy statement, now available on the Investor Relations section of the company s website, highlights its commitment to exploring strategic alternatives for maximizing shareholder value. This proactive approach underscores Enhabit s determination to evolve as a market leader in the fast-paced technology secto...
Aveanna Healthcare Holdings Inc operates as a provider of home healthcare services for pediatric patients with complex medical needs. They offer a comprehensive range of medical services and support to these patients, delivered by a team of healthcare professionals in the comfort of their own homes.
Brookdale Senior Living Inc's business model revolves around providing a variety of senior living and care services across different levels of care, including independent living, assisted living, memory care, and skilled nursing. They aim to cater to the unique needs and preferences of senior residents by creating a comfortable and supportive environment that promotes wellbeing and independence.
Chemed Corporation operates in two segments: VITAS Healthcare and Roto-Rooter. VITAS Healthcare provides hospice and palliative care services, while Roto-Rooter offers plumbing and drain cleaning services. The company generates revenue through providing these services, focusing on delivering high-quality care and maintenance solutions to its customers.
Ensign Group Inc's business model revolves around providing quality healthcare services through its network of skilled nursing and assisted living facilities.
Sources:
Enhabit Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Enhabit Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
